WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2014 full year and fourth quarter financial results before the opening of the market on February 12, 2015.
NeuroMetrix is an innovative health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders.
WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com, a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, reported today that its Chief Medical Officer ...
Neurometrix Inc (NASDAQ:NURO) has lost 2.34% during the past week and dropped 2.91% in the past 4 weeks. The shares are however, marginally negative as compared to the S&P 500 for the past week with a loss of 4.28%.